These results support the notion that restoring the circadian rhythm of the central nervous system might enhance the effectiveness in treating MASLD, in particular, PRL might serve as the chronotherapeutic target in this disease. Here, PRL is linked to metabolic dysfunction-associated steatotic liver disease.